Company Stock Information

Company Stock Data | Company Summary in Chinese | Company Press Release (84) | NAI Interview(0) | Company Event(0) | Research Report (0) | Chinese Micro Site | Contact Company
CEL-SCI CORP (AMEX:CVM)
Show Interactive Chart | Add to Portfolio

Stock Info

Last Trade 0.590
Change 0.010
Change (%) 1.6997%
Volume 322,199
10 Days Avg Vol 1,207,900
3 Months Avg Vol 49,254,800
52 Weeks Lo/Hi $ 0.54 - $ 1.3
YTD Price Gain % 25.5%
10 Wks Moving Avg $ 1
200 Days Moving Avg $ 1
Liquidity Ratio 118,700
Market Cap 17,811,618

Related News

TitleDate
CEL-SCI Enrolls 20 Patients in August in Its Phase III Immunotherapy Head and Neck Cancer Trial09/03/2014
CEL-SCI Achieves Milestone in July with Total of 232 Patients Enrolled to Date in Its Phase III Head and Neck Cancer Trial08/01/2014
CEL-SCI Receives Regulatory Clearance to Expand Phase III Head and Neck Cancer Trial into Turkey07/22/2014
CEL-SCI Expands Its Phase III Head and Neck Cancer Trial into Sri Lanka07/17/2014

Summary

Contact Info

CEL-SCI's address CEL-SCI
Suite 802 - 8229 Boone Boulevard
Vienna VA 22182
CEL-SCI's Telephne number +1 703 506-946
CEL-SCI's fax number +1 703 506-947
CEL-SCI's email account gdewindt@cel-sci.com
CEL-SCI's web site http://www.cel-sci.com
Geert R. Kersten